Publication:
PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE

dc.contributor.authorsEren, F.; Kurt, R.; Ermis, F.; Atug, O.; Imeryuz, N.; Yilmaz, Y.
dc.date.accessioned2022-03-12T16:14:12Z
dc.date.accessioned2026-01-10T18:53:52Z
dc.date.available2022-03-12T16:14:12Z
dc.date.issued2013
dc.identifier.doi10.1016/S0168-8278(13)61333-1
dc.identifier.issn0168-8278
dc.identifier.urihttps://hdl.handle.net/11424/225270
dc.identifier.wosWOS:000322983001592
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofJOURNAL OF HEPATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS537
oaire.citation.startPageS537
oaire.citation.titleJOURNAL OF HEPATOLOGY
oaire.citation.volume58

Files